Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Nanochemistry-Based Immunotherapy for HIV-1

Volume:14   Issue:18
Pp: 1911-1919
F. Lori, S.A. Calarota and J. Lisziewicz
DOI: 10.2174/092986707781368513

New Insights on the Perturbations of T Cell Cycle During HIV Infection

Volume:14   Issue:18
Pp: 1920-1924
Domenico Galati and Marialuisa Bocchino
DOI: 10.2174/092986707781368559

Eosinophilopoiesis at the Cross-Roads of Research on Development, Immunity and Drug Discovery

Volume:14   Issue:18
Pp: 1925-1939
P. Xavier Elsas and M.I. Gaspar Elsas
DOI: 10.2174/092986707781368487

Cross-Talk Between NO and Arachidonic Acid in Inflammation

Volume:14   Issue:18
Pp: 1940-1944
Sofia Mariotto, Ylenia Suzuki, Tiziana Persichini, Marco Colasanti, Hisanori Suzuki and Orazio Cantoni
DOI: 10.2174/092986707781368531

Biological Markers for Multiple Sclerosis

Volume:14   Issue:18
Pp: 1956-1965
Andreas Lutterotti, Thomas Berger and Markus Reindl
DOI: 10.2174/092986707781368478

Antileukotriene Drugs: Clinical Application, Effectiveness and Safety

Volume:14   Issue:18
Pp: 1966-1977
G. Riccioni, T. Bucciarelli, B. Mancini, C. Di Ilio and N. D'Orazio
DOI: 10.2174/092986707781368522

Monoclonal Antibody “Gold Rush”

Volume:14   Issue:18
Pp: 1978-1987
Krishan Maggon
DOI: 10.2174/092986707781368504

Hepatobiliary Diseases and Insulin Resistance

Volume:14   Issue:18
Pp: 1988-1999
Nahum Mendez-Sanchez, Noberto C. Chavez-Tapia, D. Zamora-Valdes, Roberto Medina-Santillan and Misael Uribe
DOI: 10.2174/092986707781368540

Novel Agents in the Management of Mycobacterium Tuberculosis Disease

Volume:14   Issue:18
Pp: 2000-2008
P.J. Barry and T.M. O'Connor
DOI: 10.2174/092986707781368496